Follow Us on Google
By Henry Uche
Sygen Pharmaceutical has stated that it has invested $15 million in the pharmaceutical industry of Nigeria since its inception in 2019.
It’s chief executive officer, Charles Ogunwuyi, said the company plans to drive innovation in the pharmaceutical industry with the aim of developing and creating access to high-quality medicines that yield successful outcomes and improve patients’ quality of life in the communities it operates.
He said: “There is need in the pharmaceutical industry to shift the focus from humans as patients to people living in thriving communities. Sygen Pharmaceutical puts this in practice with the goal of promoting communal well-being and thriving communities.
“We will redirect the focus on medicine as a function of ill health to providing a better life for communities’ altogether.
“As an innovative company, we had since inception established ourselves within the pharmaceutical and healthcare industry and has gained the trust and respect of key stakeholders. We will continue to grow our product portfolio across various therapeutic areas.”
He added that Sygen Pharma was poised to make a difference in the lives of people and communities: “We will strive for continuous improvement and innovations geared toward expanding access to good-quality medicines in communities.”
